Literature DB >> 24445850

Resolution of neurological deficits secondary to spontaneous intracranial haemorrhage and posterior reversible encephalopathy syndrome (PRES) in a patient with hepatitis C-associated cryoglobulinaemia: a role for plasmapheresis.

Delshad Ahmad1, Haseeb Ilias Basha, Basim Towfiq, Ghassan Bachuwa.   

Abstract

Essential mixed cryoglobulinaemia or type II cryoglobulinaemia is an important extrahepatic manifestation of chronic hepatitis C. Cryoglobulinaemia results in the deposition of immune complexes in small or medium-sized blood vessels leading to palpable purpura, arthralgia, renal disease and peripheral neuropathy. Posterior reversible encephalopathy syndrome (PRES) is a distinct phenomenon characterised by vasogenic oedema in the posterior circulation of brain. Cryoglobulinaemic vasculitis leading to spontaneous intracranial haemorrhage and PRES syndrome is rarely reported in the medical literature. In this report, we present an unusual case of spontaneous intracranial haemorrhage and PRES secondary to hepatitis C-associated cryoglobulinaemia presenting as right dense hemiplegia. Prompt institution of plasmapheresis resulted in successful resolution of symptoms in our patient, followed by full neurological recovery. To the best of our knowledge, this case describes the first successful use of plasmapheresis in alleviating neurological complications resulting from cryoglobulinaemic vasculitis and PRES secondary to chronic hepatitis C.

Entities:  

Mesh:

Year:  2014        PMID: 24445850      PMCID: PMC3902779          DOI: 10.1136/bcr-2013-202717

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Glomerulonephritis in mixed cryoglobulinaemia: what treatment?

Authors:  M Campise; A Tarantino
Journal:  Nephrol Dial Transplant       Date:  1999-02       Impact factor: 5.992

Review 2.  Therapeutic plasma exchange in renal diseases.

Authors:  F Madore; J M Lazarus; H R Brady
Journal:  J Am Soc Nephrol       Date:  1996-03       Impact factor: 10.121

3.  Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C.

Authors:  M Cicardi; B Cesana; E Del Ninno; E Pappalardo; E Silini; A Agostoni; M Colombo
Journal:  J Viral Hepat       Date:  2000-03       Impact factor: 3.728

4.  PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

Authors:  Patrice Cacoub; David Saadoun; Nicolas Limal; Damien Sene; Olivier Lidove; Jean-Charles Piette
Journal:  Arthritis Rheum       Date:  2005-03

Review 5.  Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.

Authors:  David Saadoun; Aurelien Delluc; Jean Charles Piette; Patrice Cacoub
Journal:  Curr Opin Rheumatol       Date:  2008-01       Impact factor: 5.006

Review 6.  Indications of plasma exchanges for systemic vasculitides.

Authors:  Loïc Guillevin; Christian Pagnoux
Journal:  Ther Apher Dial       Date:  2003-04       Impact factor: 1.762

7.  Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features.

Authors:  H M Hefzy; W S Bartynski; J F Boardman; D Lacomis
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-22       Impact factor: 3.825

8.  Mixed cryoglobulinemia and hepatitis C virus.

Authors:  P Cacoub; F L Fabiani; L Musset; M Perrin; L Frangeul; J M Leger; J M Huraux; J C Piette; P Godeau
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

9.  Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.

Authors:  F Lunel; L Musset; P Cacoub; L Frangeul; P Cresta; M Perrin; P Grippon; C Hoang; D Valla; J C Piette
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

10.  Near fatal posterior reversible encephalopathy syndrome complicating chronic liver failure and treated by induced hypothermia and dialysis: a case report.

Authors:  Rashmi Chawla; Daniel Smith; Paul E Marik
Journal:  J Med Case Rep       Date:  2009-03-26
View more
  1 in total

Review 1.  Neurologic manifestations of gastrointestinal and liver diseases.

Authors:  José M Ferro; Sofia Oliveira
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.